Eagle Pharma Downgraded On 'Challenging' Hospital Environment

Injectable-drug specialist Eagle Pharmaceuticals (EGRX) stock was down sharply Monday after it got a downgrade from Mizuho saying that its thesis had played out.

Eagle stock jumped 28% on June 10 when Teva Pharmaceutical Industries (TEVA) won a patent case against several generic drugmakers, including Pfizer's (PFE) Hospira unit and Sagent Pharmaceuticals (SGNT), that were trying to launch generic versions of its blood-cancer drug Treanda. In January, Teva and Eagle launched a low-volume,...

What feeling does this article give you?

#hashtags to follow:

Eagle Pharmaceuticals [+]    EGRX [+]    Monday [+]    Mizuho [+]    Eagle [+]    June 10 [+]    Teva Pharmaceutical Industries [+]    TEVA [+]    Pfizer [+]    PFE [+]    Hospira [+]    Sagent Pharmaceuticals [+]    SGNT [+]    Treanda [+]    Teva and Eagle [+]   

More #news: